The application of cure models in the presence of competing risks: A tool for improved risk communication in population-based cancer patient survival

Epidemiology

Volumn 25, Issue 5, 2014, Pages 742-748

  Eloranta, Sandra ^a   Lambert, Paul C ^a,b   Andersson, Therese M L ^a   Björkholm, Magnus ^c   Dickman, Paul W ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; CAUSE OF DEATH; COLON CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PARAMETRIC CURE MODEL; PARAMETRIC TEST; PRIORITY JOURNAL; PROBABILITY; STATISTICAL MODEL; SWEDEN; COLONIC NEOPLASMS; EPIDEMIOLOGY; FOLLOW UP; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROCEDURES; PROGNOSIS; REGISTER; RISK; RISK ASSESSMENT; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MELANOMA; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; PROBABILITY; PROGNOSIS; REGISTRIES; RISK; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN;

EID: 84905577569     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000130     Document Type: Article

References (33)

1. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103-117.
2. Perme MP, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012;68:113-120.
3. Berkson J. The calculation of survival rates. In: Walters WG, Gray HK, Priestly J, eds. Carcinoma and Other Malignant Lesions of the Stomach. Philadelphia, PA: Sanders; 1942:467-484.
4. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430.
5. R obins JM, Greenland S. Comment on causal inference without counterfactuals by A.P. Dawid. JASA: Theory Methods. 2000; 95:477-482.
6. Koller MT, Raatz H, Steyerberg EW, Wolbers M. Competing risks and the clinical community: irrelevance or ignorance? Stat Med. 2012;31: 1089-1097.
7. Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011;11:96.
8. De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A. Mixture models for cancer survival analysis: application to populationbased data with covariates. Stat Med. 1999;18:441-454.
9. Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8:576-594.
10. Sposto R. Cure model analysis in cancer: an application to data from the Children's Cancer Group. Stat Med. 2002;21:293-312.
11. T sodikov AD, Ibrahim JG, Yakovlev AY. Estimating cure rates from survival data: an alternative to two-component mixture models. J Am Stat Assoc. 2003;98:1063-1078.
12. Yu B, Tiwari RC, Cronin KA, Feuer EJ. Cure fraction estimation from the mixture cure models for grouped survival data. Stat Med. 2004;23:1733-1747.
13. Hakulinen T. On long-term relative survival rates. J Chronic Dis. 1977;30:431-443.
14. Maller R, Zhou X. Survival Analysis with Long-Term Survivors. Chichester: Wiley; 1996.
15. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27-33.
16. C ronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000;19:1729-1740.
17. Lambert PC, Dickman PW, Nelson CP, Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med. 2010;29:885-895.
18. G ordon NH. Application of the theory of finite mixtures for the estimation of 'cure' rates of treated cancer patients. Stat Med. 1990;9:397-407.
19. Binbing Yu, Tiwari RC, Feuer EJ. Estimating the personal cure rate of cancer patients using population-based grouped cancer survival data. Stat Methods Med Res. 2011;20:261-274.
20. L arson MG, Dinse GE. A mixture model for regression analysis of competing risks data. Appl Stat. 1985;34:201-211.
21. Sasieni PD, Adams J, Cuzick J. Avoidance of premature death: a new definition for the proportion cured. J Cancer Epidemiol Prev. 2002;7:165-171.
22. Yu XQ, De Angelis R, Andersson TM, Lambert PC, O'Connell DL, Dickman PW. Estimating the proportion cured of cancer: some practical advice for users. Cancer Epidemiol. 2013;37:836-842.
23. Rutherford MJ, Crowther MJ, Lambert PC. The use of restricted cubic splines to approximate complex hazard functions in the analysis of time-toevent data: a simulation study. J Statist Comput Simulat. 2013. doi:10.1080/00949655. 2013.845890.
24. Baade PD, Youlden DR, Chambers SK. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust. 2011;194:73-77.
25. Janssen-Heijnen ML, Gondos A, Bray F, et al. Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J Clin Oncol. 2010;28:2520-2528.
26. A ndersson TML, Eriksson H, Hansson J, Mansson-Brahme E, Dickman PW, Eloranta S, et al. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: A populationbased study. Cancer Epidemiol. 2014;38:93-99.
27. Eloranta S, Lambert PC, Cavalli-Bjorkman N, Andersson TM, Glimelius B, Dickman PW. Does socioeconomic status influence the prospect of cure from colon cancer-a population-based study in Sweden 1965-2000. Eur J Cancer. 2010;46:2965-2972.
28. Andersson TM, Lambert PC, Derolf AR, et al. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study. Br J Haematol. 2010;148:918-924.
29. Tai P, Yu E, Cserni G, et al. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. BMC Cancer. 2005;5:48.
30. Brenner H, Gefeller O, Hakulinen T. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer. 2004;40:326-335.
31. Cvancarova M, Aagnes B, Fosså SD, Lambert PC, Møller B, Bray F. Proportion cured models applied to 23 cancer sites in Norway. Int J Cancer. 2013;132:1700-1710.
32. Francisci S, Capocaccia R, Grande E, et al.; EUROCARE Working Group. The cure of cancer: a European perspective. Eur J Cancer. 2009;45:1067-1079.
33. Huang L, Cronin KA, Johnson KA, Mariotto AB, Feuer EJ. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Cancer. 2008;112:2289-2300.